نتائج البحث - Ute Burkard
- يعرض 1 - 3 نتائج من 3
-
1
A phase I/II multicenter, open-label, dose escalation and randomized trial of BI 836858 in patients with low- or intermediate-1-risk myelodysplastic syndrome حسب Rami S. Komrokji, Hetty E. Carraway, Ulrich Germing, Martin Wermke, Amer M. Zeidan, Eric Fu, Björn Rüter, Ute Burkard, Annika Osswald, James M. Foran
الحاوية / القاعدة Haematologica (2022-06-01)احصل على النص الكامل
مقال -
2
A phase I study of the fully human, fragment crystallizable-engineered, anti-CD-33 monoclonal antibody BI 836858 in patients with previously-treated acute myeloid leukemia حسب Sumithira Vasu, Jessica K. Altman, Geoffrey L. Uy, Martin S. Tallman, Ivana Gojo, Gerard Lozanski, Ute Burkard, Annika Osswald, Pamela James, Björn Rüter, William Blum
الحاوية / القاعدة Haematologica (2021-12-01)احصل على النص الكامل
مقال -
3
An open-label, phase I/II trial to determine the maximum tolerated dose and investigate safety, pharmacokinetics and efficacy of BI 836858, an unconjugated anti-CD33 monoclonal ant... حسب Walter Fiedler, Pau Montesinos, Christoph Schliemann, Jan Middeke, Sumithira Vasu, Christian W. Scholz, Jordi Esteve, Shoubhik Mondal, Björn Rüter, Ute Burkard, Annika Osswald, William Blum
الحاوية / القاعدة Haematologica (2022-08-01)احصل على النص الكامل
مقال